| Bid price | 3.10 | Open price | 3.06 |
|---|---|---|---|
| Ask price | 4.40 | Prev close | 3.33 |
| High price | 3.50 | Spread | 29.55% |
| Low price | 3.06 | Volume | 236,155 |
Register now for FREE live ReNeuron Group share prices, ReNeuron Group stock quotes, charts, trades and FREE ReNeuron Group company fundamentals, market news and much much more. Why not upgrade to a premium service and get ReNeuron Group Level 2 Data, indepth research tools and investor commentary for ReNeuron Group (RENE) and other London Stock Exchange equities.
Register now for FREE ReNeuron Group share price charts
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| Activites | Researches, develops and commercially exploits stem cell technologies for therapeutic and non-therapeutic applications | Reuters | RENE.L |
| ISIN | GB00B0DZML60 | Google Finance | LON:RENE |
| Share Price (p) | 3.75 | Prev. Share Price (p) | 3.33 |
|---|---|---|---|
| Shares in Issue (m) | 775 | Market Cap (£m) | 26 |
| PE Ratio (x) | -4.46 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -1.30 | PEG |
Register now for FREE ReNeuron Group company fundamentals
/* */ RNS Number : 7123D ReNeuron Group plc 21 May 2012 21 May 2012 AIM: RENE ReNeuron Group plc (the "Company") ReNeuron to present at World Stem Cells & Regenerative Medicine Congress...
ReNeuron Group has signed a new cell manufacturing contract with Angel Biotechnology Holdings, a biopharmaceutical contract manufacturer, to perform GMP drug product manufacturing services to serve the remaining part of the PISCES Phase I clinical trial of ReNeuron's ReN001 stem cell therapy for...
/* */ RNS Number : 4226D ReNeuron Group plc 16 May 2012 16 May 2012 AIM: RENE ReNeuron Group plc (the "Company") ReNeuron Signs Cell Manufacturing Contract for Completion of Stroke Clinical...
More ReNeuron Group Company News >>
Register now for FREE ReNeuron Group company news
Think this one could have the potetial to be really big... Check out the company info and post any thoughts you have... has massive potential
Register now for FREE ReNeuron Group share price discussions